title: Fanconi syndrome induced by vemurafenib: a new renal adverse event.
authors.affiliation: Department of Dermatology, Hôpital Cochin, APHP, University Paris Descartes, Paris, France.
authors.forename: Daphné
authors.initials: D
authors.lastname: Denis
authors.affiliation: Department of Dermatology, Hôpital Cochin, APHP, University Paris Descartes, Paris, France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Franck
authors.affiliation: Department of Dermatology, Hôpital Cochin, APHP, University Paris Descartes, Paris, France.
authors.forename: Fanny
authors.initials: F
authors.lastname: Fichel
authors.affiliation: Department of Nephrology, Hôpital Européen Georges Pompidou, University René Descartes, Paris, France.
authors.forename: Charlène
authors.initials: C
authors.lastname: Levi
authors.affiliation: Department of Dermatology, Hôpital Cochin, APHP, University Paris Descartes, Paris, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Dupin
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005198:Fanconi Syndrome / Q000139:chemically induced*; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib